Significance of increased human colonic permeability in response to corticotrophin-releasing hormone (CRH)

Ferrier, Laurent
January 2008
Gut;Jan2008, Vol. 57 Issue 1, p7
Academic Journal
The article reports on the significance of increased human colonic permeability in corticotrophin-releasing hormone (CRH). It discusses the pathologies of intestinal barrier impairment including gastrointestinal symptoms of non-digestive pathologies. It is not yet established whether the barrier defects are consequences or do they trigger the pathologies.


Related Articles

  • Adrenocorticotropic Hormone (ACTH). Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p9 

    An encyclopedia entry for adrenocorticotropic hormone (ACTH) is presented. The anterior pituitary gland secretes ACTH in response to corticotropin-releasing hormone. Later, it enters the blood stream and is transported to the adrenal glands, which stimulates the synthesis and release of...

  • The Roles of Corticotropin-Releasing Factor-Related Peptides and Their Receptors in the Cardiovascular System. Nazarloo, Hossein Pournajafi; Buttrick, P. M.; Saadat, H.; Dunn, A. J. // Current Protein & Peptide Science;Jun2006, Vol. 7 Issue 3, p229 

    Corticotropin-releasing factor (CRF), CRF-related peptides and their receptors are present in the central nervous system and in peripheral tissues including the immune, reproductive and cardiovascular systems. CRF and urocortin (urocortin 1) bind to the CRF receptor type 1 (CRF1 receptor) and...

  • Brain-health interactions. Hornig-Rohan, Mady // Advances: The Journal of Mind-Body Health;Summer95, Vol. 11 Issue 3, p47 

    Presents an abstract of the study titled `Priming of the anterior pituitary with corticotropin-releasing hormone in vitro does not facilitate an ACTH response to interleukin-1beta,' by D.S. Jessop and S.L. Lightman, published in `Immunology Letters.'

  • The role of hypothalamo-hypophyseal-adrenocortical system hormones in controlling pain sensitivity. Yarushkina, N. I. // Neuroscience & Behavioral Physiology;Oct2008, Vol. 38 Issue 8, p759 

    The present review addresses analysis of data demonstrating the role of the hypothalamo-hypophyseal-adrenocortical axis (HHACA) in controlling pain sensitivity. Experiments on rats have demonstrated the analgesic effects of exogenous hormones of all components of the HHACA —...

  • Reduced Cerebral Injury in CRH-R1 Deficient Mice After Focal Ischemia: A Potential Link to Microglia and Atrocytes that Express CRH-R1. Susan L. Stevens // Journal of Cerebral Blood Flow & Metabolism;Oct2003, Vol. 23 Issue 10, p1151 

    SUMMARY: Corticotropin releasing hormone (CRH) and its family of related peptides are involved in regulating physiologic responses to multiple stressors, including stroke. Although CRH has been implicated in the exacerbation of injury after stroke, the mechanism remains unclear. After ischemia,...

  • Acute adrenal insufficiency due to isolated corticotrophin deficiency. Corrall, R. J. M.; Stewart, G. W.; Ratcliffe, J. G. // Journal of the Royal Society of Medicine;Jul1979, Vol. 72 Issue 7, p530 

    The article presents a case study of a 55-year-old patient with a three-month history of periumbilical pain with nausea, vomiting and diarrhea. The patient also complained of thirst, polyuria, nocturia and weight loss, of which are symptoms of adrenocorticotrophic hormone deficiency....

  • Corticotroph Pituitary Stone. Korchi, Amine M.; Momjian, Shahan; Vargas, Maria-Isabel // Canadian Journal of Neurological Sciences;Jan2012, Vol. 39 Issue 1, p89 

    The article presents a case study of a 65-year-old woman, with a history of high blood pressure and type II diabetes, and was admitted for diverticulitis. Her corticotropin releasing hormone (CRH) test shows Cushing's disease and her magnetic resonance imaging (MRI) reveals calcified intrasellar...

  • High-Affinity CRF1 Receptor Antagonist NBI-34041: Preclinical and Clinical Data Suggest Safety and Efficacy in Attenuating Elevated Stress Response. Ising, Marcus; Zimmermann, Ulrich S; Künzel, Heike E; Uhr, Manfred; Foster, Alan C; Learned-Coughlin, Susan M; Holsboer, Florian; Grigoriadis, Dimitri E // Neuropsychopharmacology;Sep2007, Vol. 32 Issue 9, p1941 

    There is an extensive evidence that corticotropin releasing factor (CRF) is hypersecreted in depression and anxiety, and blockade of CRF could have therapeutic benefit. We report preclinical data and the results of a clinical Phase I study with the novel nonpeptide CRF1 antagonist...

  • Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission. Tringali, Giuseppe; Aubry, Jean Michel; Moscianese, Katiuscia; Zamori, Claudia; Vairano, Mauro; Preziosi, Paolo; Navarra, Pierluigi; Pozzoli, Giacomo // Journal of Psychiatry & Neuroscience;Nov2004, Vol. 29 Issue 6, p459 

    Objective: Corticotropin-releasing factor (CRF), the major adrenocorticotropic hormone (ACTH) secretagogue, acts within the brain to integrate the stress responses of the central nervous, endocrine and immune systems. The involvement of this peptide in the origin and pathophysiology of various...


Read the Article


Sign out of this library

Other Topics